We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LFC
401
DELISTED
China Life Insurance Company Ltd.
LFC
| $12.3M | 0.03% |
878,134
-503,585
| -36% | -$7.73M |
|
|
KSU
402
DELISTED
Kansas City Southern
KSU
| $12.3M | 0.03% |
111,600
+22,100
| +25% | +$2.39M |
|
403
AllianceBernstein
AB
$3.47B
| $12.2M | 0.03% |
454,715
+179,687
| +65% | +$4.79M |
|
|
CVRR
404
DELISTED
CVR Refining, LP
CVRR
| $12.1M | 0.03% |
927,936
-12,600
| -1% | -$187K |
|
405
Equinor
EQNR
$92.4B
| $12.1M | 0.03% |
509,666
-1,181,527
| -70% | -$27.1M |
|
|
RP
406
DELISTED
RealPage, Inc.
RP
| $12M | 0.03% |
233,768
-5,883
| -2% | -$294K |
|
407
MiMedx Group
MDXG
$633M
| $12M | 0.03% |
1,726,555
+1,093,038
| +173% | +$12.7M |
|
|
ABMD
408
DELISTED
Abiomed Inc
ABMD
| $12M | 0.03% |
41,100
+23,544
| +134% | +$5.97M |
|
409
Schneider National
SNDR
$6.25B
| $11.9M | 0.03% |
458,392
+251,748
| +122% | +$6.92M |
|
410
ICL Group
ICL
$6.85B
| $11.9M | 0.03% |
2,813,945
-251,834
| -8% | -$1.08M |
|
|
EFOR
411
Everforth Inc
EFOR
$1.32B
| $11.8M | 0.03% |
143,951
-37,400
| -21% | -$2.8M |
|
412
Ingevity
NGVT
$2.68B
| $11.8M | 0.03% |
159,945
+39,682
| +33% | +$2.97M |
|
413
Pegasystems
PEGA
$5.38B
| $11.7M | 0.03% |
387,264
-3,512
| -0.9% | -$94.9K |
|
|
AVP
414
DELISTED
Avon Products, Inc.
AVP
| $11.7M | 0.03% |
4,102,355
+954,529
| +30% | +$2.41M |
|
|
TWO
415
Two Harbors Investment
TWO
$1.27B
| $11.6M | 0.03% |
189,431
-266,929
| -58% | -$16.4M |
|
416
First American
FAF
$7.58B
| $11.6M | 0.03% |
+198,000
| New | +$11.6M |
|
417
Editas Medicine
EDIT
$442M
| $11.5M | 0.03% |
347,761
+173,626
| +100% | +$6.19M |
|
|
ISCA
418
DELISTED
International Speedway Corp
ISCA
| $11.5M | 0.03% |
260,754
+116,574
| +81% | +$5.07M |
|
419
Enterprise Products Partners
EPD
$81.7B
| $11.3M | 0.03% |
463,100
+355,300
| +330% | +$9.46M |
|
|
ENV
420
DELISTED
ENVESTNET, INC.
ENV
| $11.3M | 0.03% |
197,423
+171,823
| +671% | +$9.44M |
|
|
MXIM
421
DELISTED
Maxim Integrated Products
MXIM
| $11.2M | 0.03% |
+186,300
| New | +$11M |
|
422
Cencora
COR
$61.2B
| $11.2M | 0.03% |
+129,600
| New | +$12.4M |
|
|
VSTO
423
DELISTED
Vista Outdoor Inc.
VSTO
| $11.1M | 0.03% |
679,733
+570,089
| +520% | +$9.26M |
|
424
Autodesk
ADSK
$52.6B
| $11M | 0.03% |
87,900
-588,081
| -87% | -$70M |
|
|
MGLN
425
DELISTED
Magellan Health Services, Inc.
MGLN
| $10.9M | 0.03% |
101,769
+39,840
| +64% | +$4M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.